MALVERN, Pa.--(BUSINESS WIRE)--AC Lordi, a leading provider of accounting and risk management consulting and executive search, announced today that Jeff Flynn and Lisa Hilburn have been promoted to principals of the firm.
“AC Lordi is one of the few boutique consulting firms in the Philadelphia market that relies on a full-time employee base, allowing us to create meaningful long-term career opportunities for our consultants,” said AC Lordi CEO and Managing Principal Frank Lordi. “Lisa and Jeff have been leaders within our firm for over 10 years, and their clients rely on them to deliver the highest quality of service under pressure and sometimes on very short notice. I’m proud of their exceptional work and pleased to welcome them into our Principal group.”
Lisa Hilburn has been with AC Lordi for eleven years providing Controller/CFO services to emerging pharmaceutical companies such as Tengion, ViroPharma, Fibrocell Science, GenSpera, Echo Therapeutics, and TetraLogic Pharmaceuticals. Prior to AC Lordi, Lisa held accounting and finance positions at PricewaterhouseCoopers, Quaker Chemical, and US Healthcare.
Since joining AC Lordi in 2003, Jeff Flynn has assisted more than 40 clients with successful Sarbanes-Oxley programs including CPG International, Safeguard Scientifics, PhotoMedex, Shaklee, and PHH Corporation. He also helped develop the firm’s proprietary Sarbanes-Oxley methodology as well as its CFO organization scorecard. Prior to joining AC Lordi, Jeff spent several years as a manager for Deloitte providing professional auditing and accounting services to health insurance companies.
About AC Lordi
AC Lordi is one of the leading providers of accounting and risk management consulting and executive search. The company is headquartered in Malvern, PA. For more information visit: www.aclordi.com.
Copyright © 2015 AC Lordi LLC. All rights reserved. AC Lordi LLC, its subsidiaries, and their respective taglines are either trademarks or registered trademarks of AC Lordi LLC or its subsidiaries in the United States and/or other countries. All other trademarks used are owned by their respective owners.